Actively Recruiting
Observational Study of Treatment Patterns and Outcomes in Pulmonary and Extra-Pulmonary Neuroendocrine Carcinomas Across Latin America
Led by Latin American Cooperative Oncology Group · Updated on 2026-09-08
200
Participants Needed
19
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying neuroendocrine carcinomas NEC, including both pulmonary and extra-pulmonary types, in Latin America to better understand patient treatment patterns and outcomes. This observational, retrospective study aims to fill gaps in knowledge about NEC in Brazil, Mexico, Argentina, and Peru by analyzing medical records. The study is non-interventional, meaning patients receive their usual care while data is collected for research purposes. The study collects detailed information from patient medical records, including demographics, diagnosis methods, tumor characteristics, treatments received such as surgery, chemotherapy, and radiotherapy, and disease progression. Data covers patients diagnosed between August 2014 and August 2024. No experimental treatments are given, and patient care follows standard clinical practice at each site. Participants data is gathered through an electronic system without requiring additional study visits, except for consent if needed. Researchers will evaluate treatment patterns, survival outcomes like event-free survival and progression-free survival, and the expression of the DLL-3 marker over an average follow-up of 24 months. The study will help improve understanding of NEC management and outcomes in the region.
CONDITIONS
Brief Title
Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
Research Team
P
Project Manager
L
Laura Voelcker
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here